# 2026-22328: OMB Asks Which Medicine Factories Could Ramp Up Production

2026-22328, Request for Information; Reopening of Comment Period, is a Federal Register notice from Management and Budget Office published 2026-11-02, effective 2026-11-02 (as of 2026-11-03).

- Canonical: https://policyrisk.com/federal-register/2026-22328
- As of: 2026-11-03
- Plain-text twin of the page above; the HTML and this file carry the same facts.

## Facts
- Document number: 2026-22328
- Title: Request for Information; Reopening of Comment Period
- Type: Notice
- Agencies: Management and Budget Office
- Citation: 91 FR 68988
- Published: 2026-11-02
- Effective: 2026-11-02
- Comments close: not stated
- Significant: no
- Touches household money: no
- Regulation identifier numbers: none
- Last updated: 2026-11-03

## In one line

OMB Asks Which Medicine Factories Could Ramp Up Production

## Summary

The Office of Management and Budget (OMB) is giving companies and experts more time to share info about U.S. and nearby factories that make important medicines. The comment period is now open until November 27, 2026, so folks can provide details on unused production capabilities. This helps the government plan better for medicine supplies without any immediate costs or deadlines beyond the new submission date.

## Abstract

The Office of Management and Budget (OMB) published in the Federal Register a request for information (RFI) regarding new and unused (idle) domestic, U.S.-based, and near shore production capabilities for Finished Dose Forms, Active Pharmaceutical Ingredients, and Key Starting Materials associated with the Administration for Strategic Preparedness and Response (ASPR) 86 List of essential medicines. The RFI provided for a 30-day response period which closed on October 26, 2026. OMB has determined that reopening the comment period until November 27, 2026, is appropriate. This action will allow interested parties additional time to prepare information and responses.

## Effects PRIA read

No economic effects identified for this document.

## Related documents

- [2026-21316](https://policyrisk.com/federal-register/2026-21316): Managing Senior Professional Performance, 2026-10-19
- [2026-19160](https://policyrisk.com/federal-register/2026-19160): Federal Acquisition Regulation: Revolutionary Federal Acquisition Regulation Overhaul Parts 16, 17, and 35, 2026-09-18
- [2025-10610](https://policyrisk.com/federal-register/2025-10610): Federal Acquisition Regulation: Small Business Participation on Certain Multiple-Award Contracts, 2025-06-12
- [2025-08022](https://policyrisk.com/federal-register/2025-08022): Federal Acquisition Regulation: List of Domestically Nonavailable Articles, 2025-05-12
- [2026-20271](https://policyrisk.com/federal-register/2026-20271): Information Collection; Federal Acquisition Regulation Part 11 Requirements, 2026-10-02
- [2026-20270](https://policyrisk.com/federal-register/2026-20270): Information Collection; Presolicitation Notice and Response, 2026-10-02

## Sources
- [2026-22328 on federalregister.gov](https://www.federalregister.gov/documents/2026/11/02/2026-22328/request-for-information-reopening-of-comment-period)
- [2026-22328 as published (PDF)](https://www.govinfo.gov/content/pkg/FR-2026-11-02/pdf/2026-22328.pdf)

## Related
- [Previous: 2026-22327, New England Fishery Management Council; Public Meeting](https://policyrisk.com/federal-register/2026-22327)
- [Next: 2026-22329, Agency Forms Undergoing Paperwork Reduction Act Review](https://policyrisk.com/federal-register/2026-22329)
- [All Federal Register documents](https://policyrisk.com/federal-register)

Source: PRIA, https://policyrisk.com/federal-register/2026-22328 (as of 2026-11-03).